Literature DB >> 22042420

[The effect of periampullary diverticulum on the outcome of bile duct stone treatment with endoscopic papillary large balloon dilation].

Ji Won Lee1, Jung Ho Kim, Yeon Suk Kim, Hyun Seok Choi, Ju Seung Kim, Seok Hoo Jeong, Min Su Ha, Yang Suh Ku, Yun Soo Kim, Ju Hyun Kim.   

Abstract

BACKGROUND/AIMS: Periampullary diverticulum (PAD) causes difficulty in the extraction of common bile duct (CBD) stones with conventional endoscopic therapy. Our study was designed to evaluate the effect of PAD on endoscopic large balloon dilation (EPLBD) with/without limited endoscopic sphincterotomy (EST) for CBD stone treatment.
METHODS: We retrospectively reviewed cases of 141 patients treated CBD stones by EPLBD with/without limited EST at Gachon Gil Medical Center from September 2008 to February 2010. PAD were classified into three groups according to the location of the papilla and diverticulum. Clinical parameters, endoscopic parameters, and procedure outcomes were analyzed.
RESULTS: PAD were identified in 46.1% (65/141), with 23 male (35.4%) and 42 female (64.6%) and a mean age of 72.9±11.1 years. Mean diameter of the stones was 14.8±6.0 mm and mean diameter of CBD was 21.6±7.7 mm. PAD group was significantly older than control group (72.9 vs. 68.6, p=0.043) and the incidence of large stone (≥15 mm) was higher in PAD group (60.0% vs. 42.1%, p=0.034). Success rate of complete removal of stones in the first session was 32/65 patients (49.2%) and overall successful complete stone removal rates was 63/65 (96.9%). There was no significant difference between the PAD and control groups in success rate. Major complications were similar between two groups.
CONCLUSIONS: PAD is associated with an increased incidence of large bile duct stones and older age. PAD seems to not increase technical failure rate or complication risk on EPLBD with/without limited EST.

Entities:  

Mesh:

Year:  2011        PMID: 22042420     DOI: 10.4166/kjg.2011.58.4.201

Source DB:  PubMed          Journal:  Korean J Gastroenterol        ISSN: 1598-9992


  7 in total

Review 1.  Endoscopic papillary large balloon dilation for the removal of bile duct stones.

Authors:  Jin Hong Kim; Min Jae Yang; Jae Chul Hwang; Byung Moo Yoo
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

2.  Biliary boulders.

Authors:  H Steed; K Lau; R Glass; D Durkin; M Deakin; J R B Green
Journal:  Frontline Gastroenterol       Date:  2014-01-08

3.  Endoscopic papillary large balloon dilatation with sphincterotomy is safe and effective for biliary stone removal independent of timing and size of sphincterotomy.

Authors:  Usman Iqbal Aujla; Nimzing Ladep; Laura Dwyer; Stephen Hood; Nicholas Stern; Richard Sturgess
Journal:  World J Gastroenterol       Date:  2017-12-28       Impact factor: 5.742

4.  Endoscopic papillary balloon dilation after sphincterotomy for difficult choledocholithiasis: A case-controlled study.

Authors:  Bruno Rosa; Pedro Moutinho Ribeiro; Ana Rebelo; António Pinto Correia; José Cotter
Journal:  World J Gastrointest Endosc       Date:  2013-05-16

5.  Endoscopic papillary balloon dilation for difficult common bile duct stones: Our experience.

Authors:  Maddalena Zippi; Isabella De Felici; Roberta Pica; Giampiero Traversa; Giuseppe Occhigrossi
Journal:  World J Clin Cases       Date:  2013-04-16       Impact factor: 1.337

Review 6.  Is endoscopic papillary large balloon dilation safe for treating large CBD stones?

Authors:  Chan Sup Shim; Ji Wan Kim; Tae Yoon Lee; Young Koog Cheon
Journal:  Saudi J Gastroenterol       Date:  2016 Jul-Aug       Impact factor: 2.485

7.  What Is the Value of the Learning Curve in Endoscopic Balloon Dilatation of the Major Papilla?

Authors:  Eduardo Tavio-Hernandez; Enrique Vazquez-Sequeiros; Enrique Rodriguez-Santiago; Juan Angel Gonzalez-Martin; Jose Ramón Foruny-Olcina; Vicente Benita-Leon; Victor Defarges-Pons; Daniel Boixeda-Miquel; Agustin Albillos-Martínez
Journal:  Gastroenterol Res Pract       Date:  2017-08-16       Impact factor: 2.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.